ADMA
ADMA Biologics Inc
NASDAQ: ADMA · HEALTHCARE · BIOTECHNOLOGY
$10.60
-2.75% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
17.67
P/S ratio
4.83x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$7 – $24
Volume
6.8M
ADMA Biologics Inc (ADMA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
28.80%
Operating margin
-123.40%
ROE
35.60%
ROA
21.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-29.69M | — | — | — |
| 2007 | — | $-29.69M | — | — | — |
| 2008 | — | $-24.89M | — | — | — |
| 2009 | — | $-20.01M | — | — | — |
| 2010 | — | $-20526.00 | — | — | — |
| 2011 | — | $-26460.00 | — | — | — |
| 2012 | $1.12M | $-7.30M | 40.16% | -707.36% | -653.00% |
| 2013 | $3.07M | $-15.53M | 34.04% | -490.37% | -506.17% |
| 2014 | $5.92M | $-16.81M | 36.74% | -270.79% | -284.22% |
| 2015 | $7.18M | $-17.97M | 39.93% | -216.14% | -250.36% |
| 2016 | $10.66M | $-19.52M | 40.34% | -162.56% | -183.05% |
| 2017 | $22.76M | $-43.76M | -28.14% | -172.71% | -192.26% |
| 2018 | $16.99M | $-65.74M | -148.42% | -354.95% | -387.06% |
| 2019 | $29.35M | $-48.28M | -34.60% | -141.14% | -164.50% |
| 2020 | $42.22M | $-75.75M | -45.17% | -153.75% | -179.41% |
| 2021 | $80.94M | $-71.65M | 1.45% | -72.12% | -88.52% |
| 2022 | $154.08M | $-65.90M | 22.89% | -25.55% | -42.77% |
| 2023 | $258.21M | $-28.24M | 34.44% | 8.38% | -10.94% |
| 2024 | $426.45M | $197.67M | 51.48% | 32.59% | 46.35% |
| 2025 | $510.17M | $146.93M | 57.39% | 37.53% | 28.80% |